Oxigene Inc.
Oxigene Inc.
OXiGENE is developing the next generation of vascular therapies.
Website URL : http://www.oxigene.com
Stock Ticker : OXGN
Oxigene Inc.
OXiGENE is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases. The company’s major focus is developing vascular disrupting agents (VDAs) that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.